Moreover, Bach2 overexpression significantly repressed the levels of IL‐9, whereas IRF4 overexpression notably enhanced the levels of IL‐9 in the CD4+ T cells from SLE patients and healthy volunteers. Here, IRF4 is linked to systemic lupus erythematosus.